8-OHdG Inhibitors

Common 8-OHdG Inhibitors include, but are not limited to N-Acetyl-L-cysteine CAS 616-91-1, 5,7-Dihydroxy-4-methylcoumarin CAS 2107-76-8, Baicalein CAS 491-67-8, DL-α-Tocopherol CAS 10191-41-0 and Tiron CAS 149-45-1.

8-OHdG inhibitors belong to a class of compounds designed to modulate the levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG), a modified nucleoside that results from the oxidation of guanine in DNA. This chemical modification can occur as a consequence of oxidative stress, DNA damage, or exposure to reactive oxygen species. Elevated levels of 8-OHdG are often associated with cellular and molecular damage, as it can lead to mutations and genomic instability. By targeting the mechanisms underlying the formation of 8-OHdG or its subsequent effects, these inhibitors aim to mitigate the harmful consequences of oxidative damage to DNA.

Research on 8-OHdG inhibitors contributes to our understanding of the intricate pathways involved in DNA repair, oxidative stress responses, and genomic stability. These inhibitors are valuable tools for probing the role of 8-OHdG in various cellular processes. By modulating the levels of 8-OHdG, these inhibitors offer insights into the complex interplay between oxidative stress and DNA damage, shedding light on strategies for maintaining DNA integrity and mitigating the harmful effects of oxidative damage on cellular function.